Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Refractory lupus erythematosus tumidus responsive to tildrakizumab.

Ismail FF, Sinclair RD, Pinczewski J.

Dermatol Ther. 2019 Sep;32(5):e13070. doi: 10.1111/dth.13070. Epub 2019 Sep 3. No abstract available.

PMID:
31442369
2.

Patterns of immune-cell infiltration in murine models of melanoma: roles of antigen and tissue site in creating inflamed tumors.

Leick KM, Pinczewski J, Mauldin IS, Young SJ, Deacon DH, Woods AN, Bosenberg MW, Engelhard VH, Slingluff CL Jr.

Cancer Immunol Immunother. 2019 Jul;68(7):1121-1132. doi: 10.1007/s00262-019-02345-5. Epub 2019 May 27.

PMID:
31134297
3.

Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk.

Salerno EP, Bedognetti D, Mauldin IS, Deacon DH, Shea SM, Pinczewski J, Obeid JM, Coukos G, Wang E, Gajewski TF, Marincola FM, Slingluff CL Jr.

Oncoimmunology. 2016 Oct 18;5(12):e1240857. doi: 10.1080/2162402X.2016.1240857. eCollection 2016.

4.

Porcine acellular dermal matrix (PADM) vascularises after exposure in open necrotic wounds seen after complex hernia repair.

Gowda AU, Chang SM, Chopra K, Matthews JA, Sabino J, Stromberg JA, Zahiri HR, Pinczewski J, Holton LH 3rd, Silverman RP, Singh DP.

Int Wound J. 2016 Oct;13(5):972-6. doi: 10.1111/iwj.12558. Epub 2015 Dec 21. Review.

PMID:
26688300
5.

MHC-restricted phosphopeptides from insulin receptor substrate-2 and CDC25b offer broad-based immunotherapeutic agents for cancer.

Zarling AL, Obeng RC, Desch AN, Pinczewski J, Cummings KL, Deacon DH, Conaway M, Slingluff CL Jr, Engelhard VH.

Cancer Res. 2014 Dec 1;74(23):6784-95. doi: 10.1158/0008-5472.CAN-14-0043. Epub 2014 Oct 8.

6.

Something to Reed about: fibroids, cutaneous leiomyomas, and renal cell carcinoma.

Orseth ML, Redick D, Pinczewski J, Wilson BB, Kuppalli SS.

Am J Obstet Gynecol. 2014 Jun;210(6):584.e1-2. doi: 10.1016/j.ajog.2014.03.008. Epub 2014 Mar 5.

PMID:
24613222
7.

Symptomatic squamous papilloma of the uvula: report of a case and review of the literature.

Goodstein LA, Khan A, Pinczewski J, Young VN.

Case Rep Otolaryngol. 2012;2012:329289. doi: 10.1155/2012/329289. Epub 2012 Apr 17.

8.

A patient with AIDS with fungating lesions of the face and scalp.

Osinusi O, Greisman L, Menajovsky J, Pinczewski J, Ghosh M.

Clin Infect Dis. 2011 Apr 15;52(8):1029-30, 1077-8. doi: 10.1093/cid/cir030. No abstract available.

PMID:
21460319
9.
10.

A multiplex real-time PCR method for quantification of BK and JC polyomaviruses in renal transplant patients.

Rubio L, Pinczewski J, Drachenberg CB, Vera-Sempere FJ, Zhao RY.

Diagn Mol Pathol. 2010 Jun;19(2):105-11. doi: 10.1097/PDM.0b013e3181c37199.

PMID:
20502188
11.

Aberrant VEGF expression associated with neoplasm-induced extramedullary hematopoiesis in an epithelioid hemangioendothelioma: a case report.

Pinczewski J, Papadimitriou JC.

Int J Surg Pathol. 2011 Oct;19(5):662-6. doi: 10.1177/1066896909356922. Epub 2010 Jan 13.

PMID:
20075024
12.

Enhanced immunity and protective efficacy against SIVmac251 intrarectal challenge following ad-SIV priming by multiple mucosal routes and gp120 boosting in MPL-SE.

Pinczewski J, Zhao J, Malkevitch N, Patterson LJ, Aldrich K, Alvord WG, Robert-Guroff M.

Viral Immunol. 2005;18(1):236-43.

PMID:
15802969
13.

Evaluation of combination DNA/replication-competent Ad-SIV recombinant immunization regimens in rhesus macaques.

Malkevitch N, Rohne D, Pinczewski J, Aldrich K, Kalyanaraman VS, Letvin NL, Robert-Guroff M.

AIDS Res Hum Retroviruses. 2004 Feb;20(2):235-44.

PMID:
15018712
14.

Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting.

Patterson LJ, Malkevitch N, Venzon D, Pinczewski J, Gómez-Román VR, Wang L, Kalyanaraman VS, Markham PD, Robey FA, Robert-Guroff M.

J Virol. 2004 Mar;78(5):2212-21.

15.

Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants.

Zhao J, Lou Y, Pinczewski J, Malkevitch N, Aldrich K, Kalyanaraman VS, Venzon D, Peng B, Patterson LJ, Edghill-Smith Y, Woodward R, Pavlakis GN, Robert-Guroff M.

Vaccine. 2003 Sep 8;21(25-26):4022-35.

PMID:
12922139
16.

Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120.

Patterson LJ, Malkevitch N, Pinczewski J, Venzon D, Lou Y, Peng B, Munch C, Leonard M, Richardson E, Aldrich K, Kalyanaraman VS, Pavlakis GN, Robert-Guroff M.

J Virol. 2003 Aug;77(16):8607-20.

17.

Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen.

Zhao J, Pinczewski J, Gómez-Román VR, Venzon D, Kalyanaraman VS, Markham PD, Aldrich K, Moake M, Montefiori DC, Lou Y, Pavlakis GN, Robert-Guroff M.

J Virol. 2003 Aug;77(15):8354-65.

18.

Effects of intestinal survival surgery on systemic and mucosal immune responses in SIV-infected rhesus macaques.

Edghill-Smith YY, Aldrich K, Zhao J, Pinczewski J, Kalyanaraman VS, Johnson M, Heyliger A, Perrin RP, Woodward R, Robert-Guroff M.

J Med Primatol. 2002 Dec;31(6):313-22.

PMID:
12519209

Supplemental Content

Loading ...
Support Center